References
- Hoffman BJ. Sensitivity to sulphadiazine resembling acute disseminated lupus erythematosus. Arch Dermatol 1945: 51: 190–2
- Weinstein A. Drug-induced systemic lupus erythematosus. In: Schwartz RS, ed. Progress in clinial immunology. Vol 4. New York: Grune & Stratton, 1980: 1–21
- Hess EV. Introduction to drug-related lupus. Arthritis Rheum 1981: 24(8): VI–IX
- Lee SL, Chase PH. Drug-induced systemic lupus erythematosus: a critical review. Semin Arthritis Rheum 1975: 5(1): 83–103
- Harmon CE, Portanova JP. Drug-induced lupus: clinical and serological studies. Clin Rheum Dis 1982: 8(1): 121–35
- Uetrecht JP, Freeman RW, Woosley RL. The implications of procainamide metabolism to its induction of lupus. Arthritis Rheum 1981: 24(8): 994–1003
- Uetrecht JP, Woosley RL. Acetylator phenotype and lupus erythematosus. Clin Pharmacokinet 1981: 6(2): 118–34
- Proceedings of the Kroc Foundation Conference on Drug-Induced Lupus. Arthritis Rheum 1981: 24(8): 979–1112
- Schoen RT, Trentham D. Drug-induced lupus: an adjuvant disease? Am J Med 1981: 71(1): 5–8
- McKenna CH, Wieman KC, Shulman LB. Oral contraceptives, rheumatic diseases and auto-antibodies. Arthritis Rheum 1969: 12: 313–4